HealthCare Global Enterprises Limited (HCG) Q4 2025 Earnings – Full Coverage скачать в хорошем качестве

HealthCare Global Enterprises Limited (HCG) Q4 2025 Earnings – Full Coverage

*HealthCare Global Enterprises Limited (HCG) Q4 2025 Earnings – Full Coverage* *Key Highlights:* *Financials* – Q4 revenue $69,030K USD, up 18% YoY; FY25 revenue $262,314K USD, up 16%; EBITDA $46,686K USD, up 17%; $500B global healthcare market. *Operations* – 13.8% outpatient growth; 24% chemotherapy rise; Vizag expansion; tariffs impact ~1% via India focus. *Strategy* – Chairman B.S. Ajaikumar emphasized precision medicine; CEO Raj Gore focused digital growth; CFO Ruby Vitolia targeted efficiency; tariffs mitigated via local operations. *Outlook* – FY26 targets 20%+ EBITDA margin; 900 beds by 2028; KKR investment to reduce debt. *Timestamps:* [00:00] – Opening Remarks and Introduction [00:56] – Chairman Update: Strategic Vision (B.S. Ajaikumar) [05:55] – CEO Update: Operational Highlights (Raj Gore) [12:14] – CFO Update: Financial Performance (Ruby Vitolia) [18:18] – Q&A Session Begins [20:36] – Q&A: Margin Profile (Gautam Rajesh, Everflow Partners) [24:53] – Q&A: PAT Growth Strategy (MIPL Sandy) [29:30] – Q&A: Receivables, Vizag (Devang Patel, Samixa Capital) [36:04] – Q&A: Bed Expansion, ARPU (Aditha Chirra, Incred Asset Management) [38:36] – Q&A: Digital Revenue, Tax Rate (Kashish Thakur, Ilara Capital) [51:48] – Q&A: International Patients, Milan (Tratav Securities) *Keywords:* HCG, Q4 2025 earnings, oncology, precision medicine, digital health, KKR *Buy, Hold, or Sell?* HealthCare Global Enterprises Limited (HCG) is a BUY. Q4 revenue up 18% to $69,030K USD and FY25 EBITDA up 17% to $46,686K USD in a $500B global healthcare market, with strong oncology growth, signal robust potential; Milan losses and debt warrant monitoring. Tariff impact, ~1%, is minimal due to India-centric operations. *Max Position* – Allocate 2-3% in a diversified portfolio. *Comment below with your thoughts! Subscribe for more updates!* *Full Details:* [HCG Investor Relations](https://www.hcgoncology.com/investors) *Disclaimer:* This video includes segments from the earnings call by HealthCare Global Enterprises Limited, used solely for educational and informational purposes under fair use (Section 107, US Copyright Act). No affiliation or endorsement by HCG is implied. All rights to the original content remain with the company. For the official call, visit [https://www.hcgoncology.com/investors](https://www.hcgoncology.com/investors). For inquiries or requests for removal, please contact us at [email protected].